This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trilles, L.
Right arrow Articles by Guarro, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trilles, L.
Right arrow Articles by Guarro, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2005, p. 3952-3954, Vol. 49, No. 9
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.9.3952-3954.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

In Vitro Antifungal Susceptibilities of Sporothrix schenckii in Two Growth Phases

Luciana Trilles,1 Belkys Fernández-Torres,2 Márcia dos Santos Lazéra,1 Bodo Wanke,1 Armando de Oliveira Schubach,1 Rodrigo de Almeida Paes,1 Isabel Inza,2 and Josep Guarro2*

Serviço de Micologia Médica, Instituto de Pesquisa Clínica Evandro Chagas, FIOCRUZ, Rio de Janeiro, Brazil,1 Unitat de Microbiologia, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, Reus, Spain2

Received 28 December 2004/ Returned for modification 5 January 2005/ Accepted 5 June 2005

We have determined the antifungal susceptibilities of 34 clinical isolates of the dimorphic fungus Sporothrix schenckii to 11 drugs using a microdilution method. In general, the type of growth phase (mycelial or yeast) and the temperature of incubation (30 or 35°C) exerted a significant influence on the MICs.

* Corresponding author. Mailing address: Unitat de Microbiología, Facultat de Medicina, Universitat Rovira i Virgili, Carrer Sant Llorenç, 21, 43201 Reus, Spain. Phone: 34-977-759359. Fax: 34-977-759322. E-mail: josep.guarro{at}urv.net.

Antimicrobial Agents and Chemotherapy, September 2005, p. 3952-3954, Vol. 49, No. 9
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.9.3952-3954.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Marimon, R., Serena, C., Gene, J., Cano, J., Guarro, J. (2008). In Vitro Antifungal Susceptibilities of Five Species of Sporothrix. Antimicrob. Agents Chemother. 52: 732-734 [Abstract] [Full Text]  
  • Marimon, R., Cano, J., Gene, J., Sutton, D. A., Kawasaki, M., Guarro, J. (2007). Sporothrix brasiliensis, S. globosa, and S. mexicana, Three New Sporothrix Species of Clinical Interest. J. Clin. Microbiol. 45: 3198-3206 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»